Nwam LLC Gilead Sciences, Inc. Transaction History

Nwam LLC

$339 Million
Q2 2024

A detailed history of Nwam LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nwam LLC holds 16,586 shares of GILD stock, worth $1.46 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

16,586

Previous 16,029 3.47%

Holding current value

$1.46 Million

Previous $1.17 Million 3.15%

% of portfolio

0.34%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $35,174 - $40,594	557 Added 3.47%	16,586 $1.14 Million
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $84,679 - $103,264	-1,183 Reduced 6.87%	16,029 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $109,172 - $123,804	1,490 Added 9.48%	17,212 $1.39 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $155,126 - $169,245	-2,098 Reduced 11.77%	15,722 $1.18 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $76,162 - $86,873	-1,002 Reduced 5.32%	17,820 $1.37 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $12,292 - $14,004	-159 Reduced 0.84%	18,822 $1.56 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $81,389 - $116,847	1,306 Added 7.39%	18,981 $1.63 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $59,718 - $68,214	-1,003 Reduced 5.37%	17,675 $1.09 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $97,546 - $109,866	-1,690 Reduced 8.3%	18,678 $1.16 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $221,544 - $277,618	-3,825 Reduced 15.81%	20,368 $1.21 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $541,099 - $614,157	8,340 Added 52.61%	24,193 $1.76 Million
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $169,766 - $183,159	2,508 Added 18.79%	15,853 $1.11 Million
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $19,548 - $21,359	308 Added 2.36%	13,345 $919,000
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $119,400 - $136,235	1,990 Added 18.01%	13,037 $843,000
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $114,206 - $130,132	-2,016 Reduced 15.43%	11,047 $644,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $272,122 - $342,146	-4,382 Reduced 25.12%	13,063 $825,000
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $15,842 - $18,396	219 Added 1.27%	17,445 $1.34 Million
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $116,742 - $149,530	1,864 Added 12.13%	17,226 $1.29 Million
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $110,916 - $122,004	1,800 Added 13.27%	15,362 $998,000
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $39,318 - $43,401	629 Added 4.86%	13,562 $860,000
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $55,683 - $62,441	900 Added 7.48%	12,933 $874,000
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $75,411 - $84,480	-1,206 Reduced 9.11%	12,033 $782,000
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $36,384 - $47,479	-601 Reduced 4.34%	13,239 $828,000
Q3 2018 Oct 09, 2018	BUY	$71.28 - $78.92 $13,115 - $14,521	184 Added 1.35%	13,840 $1.07 Million
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $13,300 - $15,514	-205 Reduced 1.48%	13,656 $967,000
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $25,712 - $31,346	-353 Reduced 2.48%	13,861 $1.05 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $162,435 - $190,676	-2,283 Reduced 13.84%	14,214 $1.02 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $1.19 Million - $1.41 Million	16,497	16,497 $1.34 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account